Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.7.0.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
6 Months Ended
Jun. 30, 2017
USD ($)
$ / shares
shares
Equity [Abstract]  
Stock option outstanding, beginning balance | shares
Stock option outstanding, granted | shares 19,250,000
Stock option outstanding, cancelled | shares
Stock option outstanding, exercised | shares
Stock option outstanding, ending balance | shares 19,250,000
Stock option outstanding, exercisable | shares 19,250,000
Stock option, Weighted average fair value of options granted during the period | $ $ 19,250,000
Weighted average exercise price, beginning balance
Weighted average exercise price, granted 0.054
Weighted average exercise price, cancelled
Weighted average exercise price, exercised
Weighted average exercise price, ending balance 0.054
Weighted average exercise price, exercisable 0.054
Weighted average exercise price, Weighted average fair value of options granted during the period $ 0.052
Weighted average remaining contractual term (years), beginning balance 0 years
Weighted average remaining contractual term (years), granted 9 years 11 months 8 days
Weighted average remaining contractual term (years), ending balance 9 years 11 months 8 days
Weighted average remaining contractual term (years), exercisable 9 years 11 months 8 days
Aggregated intrinsic value (1), beginning balance | $
Aggregated intrinsic value (1), ending balance | $
Aggregated intrinsic value (1), exercisable | $